Conatus Pharmaceuticals

Conatus Pharmaceuticals appoints Morris as head of biostatistics

Thursday, July 19, 2012 08:16 AM

Conatus Pharmaceuticals, a San Diego-based privately held biopharmaceutical company focused on fibrotic disease and oncology, has appointed Mark F. Morris as head of biostatistics.

More... »


Conatus Pharmaceuticals begins phase II trial of CTS-1027 for hepatitis C

Tuesday, March 1, 2011 08:03 AM

Conatus Pharmaceuticals has treated its first patient in a multi-center phase IIb clinical trial evaluating CTS-1027 in combination with Peginterferon Alfa-2a (PegasysR) and ribavirin (CopegusR) in a treatment experienced, hepatitis C (HCV) null responder patient population.

More... »



CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs